Project Grant R21NS142498
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $462,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective April 1, 2026, through March 31, 2028. The award supports research investigating therapeutic interventions to reduce brain injury and hydrocephalus in premature neonates with intraventricular...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded J. David Gladstone Institutes a Project Grant of $1,375,478 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through August 31, 2033. This eight-year award supports multidisciplinary research investigating neurovascular dysfunction and its role in neurodegeneration, central nervous system (CNS)...
- Federal Project Grant Award Summary Award Details: The National Institute of Neurological Disorders and Stroke (NINDS) awarded Baylor College of Medicine a Project Grant totaling $1,265,552 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The five-year award commenced August 1, 2025, and will conclude April 30, 2030, with research to be conducted in Houston, Texas. Research Objectives and Deliverables: This project advances fundamental...
- Federal Project Grant Award Summary Brigham and Women's Hospital Inc. received a $549,256 Project Grant awarded on June 6, 2025, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a five-year research project with a completion date of May 31, 2030, investigating the regulation of astrocyte responses in central nervous system (CNS) inflammation, with...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $219,372 Project Grant to Albert Einstein College of Medicine on May 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This five-year career development and research initiative, scheduled for completion by April 30, 2031, supports a neurosurgeon-scientist's investigation into tumor-mediated immune suppression in...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $670,266 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective January 20, 2026, and extending through December 31, 2030, funds research to map the epigenomic and spatial transcriptomic landscape in Parkinson's Disease and Alzheimer's...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $491,163 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective August 1, 2025, through July 31, 2027, supports research investigating the mechano-electrical regulation of neurogenesis during brain development. The research explores how inner...
- Federal Project Grant Award Summary Augusta University Research Institute, Inc. (AURI), doing business as Georgia Health Sciences, received a $462,933 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective January 1, 2026, through December 31, 2030. The award funds basic neuroscience research investigating spreading depolarization (SD)—waves of...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Maryland, Baltimore a Project Grant of $427,625 on July 17, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research through June 30, 2027, focused on developing a comprehensive toolbox to study proteome plasticity in brain endothelial cells. The research addresses critical gaps in...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Missouri System a $622,881 Project Grant on August 5, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support research on novel mechanisms of metabolic reprogramming of reactive astrocytes and brain repair after focal cerebral ischemia (FCI). The five-year award extends through July 31, 2030, and is being...
Albert Einstein College of Medicine received a $462,000 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 5, 2026, with completion targeted for April 30, 2028. The research project investigates astrocyte response to glymphatic shear forces, with the primary objective of quantifying how astrocyte endfeet respond to mechanical forces along the glia limitans and determining the transduction mechanisms contributing to brain hemorrhage and cerebral edema. The deliverables include experimental research utilizing calcium imaging in microfluidic devices, pharmacological and genetic deletion studies, brain slice imaging analysis, and super-resolution microscopy to localize endfoot proteins and their interactions in infarct regions. The research specifically examines astrocyte sensitivity to shear stress mediated by the mechanosensor Piezo1 in both basal and reactive states using mouse and human astrocyte models. Findings are expected to advance understanding of glymphatic flow regulation and clearance of amyloid and cellular debris from brain extracellular space, with potential therapeutic implications for restoring normal glymphatic function in aging and neurological diseases such as Alzheimer's disease.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $462.0k | 5/5/26 |